Log In
BCIQ
Print this Print this
 

IBL-301

  Manage Alerts
Collapse Summary General Information
Company Inflection Biosciences Ltd.
DescriptionPIM, PI3K, and mTOR inhibitor
Molecular Target Pim-1 (PIM1) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor; PIM1 inhibitor; Phosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today